小剂量丙戊酸钠对双相情感障碍患者认知功能的影响及安全性研究

doi:10.3969/j.issn.1001-8131.2025.02.010

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (510 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect and safety of low-dose valproate on cognitive function in patients with bipolar disorder（BPD）.Methods A retrospective study was conducted on 115 patients with BPD.Groups A,B,and C were set up according to different treatment doses of sodium valproate,with 40,40,and 35 patients in each group.Group A received 10mg/kg valproate,Group B 15mg/kg valproate and Group C 20mg/kg valproate.Comparing three groups of general data and clinical efficacy,test the plasma concentration related indicators（mean plasma concentration,steady state plasma concentration trough time）,and evaluate the three groups of young manic rating scale（YMRS）,the Montreal cognitive assessment scale（MoCA）score and liver function indicators[alanine aminotransferase（ALT）,glutamase aminotransferase（AST）,total bilirubin（TBIL）]level,and finally compare the adverse reactions.Results The total effective rates of the three groups were comparable（P>0.05）;The average blood drug concentrations of the three groups were comparable（P>0.05）;Compared with group A,groups B and C had shorter time to reach the steady-state blood drug concentration trough（P<0.05）;Multiple linear regression was used to correct the baseline data of three groups.Before treatment and 2 months after treatment,the MoCA and YMRS scores of the three groups were comparable（P>0.05）;Two months after treatment,YMRS scores decreased and MoCA scores increased in all three groups compared to before treatment（P<0.05）;Before treatment,the liver function levels of the three groups were comparable（P>0.05）;Two months after treatment,the liver function levels of all three groups increased compared to before treatment,and group A had a lower level（P<0.05）;Compared with groups B and C（17.50%,31.43%）,group A had a lower overall incidence of adverse reactions at 7.50%（P<0.05）.Conclusion 10mg/kg,15mg/kg,20mg/kg and 20 mg/kg of BPD can improve manic and depressive symptoms and cognitive function.However,10mg/kg of valproate had the least effect on liver function and had high safety.

Key words： Sodium valproate bipolar disorder cognitive function safety and liver function

Received: 16 February 2025

PACS:

R749.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Li Yu
	Zhang Ying
	Fu YanMei

Cite this article:

Li Yu,Zhang Ying,Fu YanMei. The Effect and Safety of Low-dose Sodium Valproate on Cognitive Function in Patients with Bipolar Disorder[J]. journal1, 2025, 45(2): 33-36.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2025.02.010 OR http://www.hrbyybjb.org.cn/EN/Y2025/V45/I2/33

[1] Nierenberg AA,Agustini B,Khler-Forsberg O,et al.Diagnosis and Treatment of Bipolar Disorder:A Review[J].JAMA.2023,330(14):1370-1380.
[2] Salvi V,Ribuoli E,Servasi M,et al.ADHD and Bipolar Disorder in Adulthood:Clinical and Treatment Implications[J].Medicina(Kaunas).2021,57(5):466.
[3] Bohlken J,Riedel-Heller S,Bauer M,et al.Bipolar Disor-der and Outcomes of Monotherapy with Lithium,Valpr-oate,Quetiapine,Olanzapine,Venlafaxine,and Citalopram[J].Pharmacopsychiatry.2021,54(3):126-130.
[4] Yee CS,Vázquez GH,Hawken ER,et al.Long-Term Treatment of Bipolar Disorder with Valproate:Updated Systematic Review and Meta-analyses[J].Harv Rev Psychiatry.2021,29(3):188-195.
[5] 董景五. 疾病和有关健康问题的国际统计学分类:ICD-10.第1卷[M].北京:人民卫生出版社,2008:242-245.
[6] 金金,何燕玲,周亮,等.精神病症状维度评定量表中文版的效度和信度[J].中国心理卫生杂志,2020,34(11):932-939.
[7] 蒙特利尔认知评估量表(MoCA)[J].中华神经外科杂志,2012,28(12):1242-1243.
[8] 刘珊珊,房萌,朱虹,等.2010年和2019年双相情感障碍住院患者的临床特征和未治疗持续时间的因素分析[J].首都医科大学学报,2022,43(3):415-420.
[9] 闫爱国,刘鑫子,尹冬青,等.双相情感障碍复发相关的社会心理特征因素研究[J].首都医科大学学报,2023,44(4):602-608.
[10] 余浩,吴瑶,邹韶红.双相情感障碍认知功能损害与脑源性神经营养因子基因遗传学研究的进展[J].神经疾病与精神卫生,2023,23(12):895-900.
[11] Kishi T,Ikuta T,Matsuda Y,et al.Pharmacological treatment for bipolar mania:a systematic review and network meta-analysis of double-blind randomized controlled trials[J].Mol Psychiatry.2022,27(2):1136-1144.
[12] Faridhosseini F,Talaei A,Shahini N,et al.Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder A double-blind controlled clinical trial in Iran[J].Int Clin Psychopharmacol.2023,38(5):336-341.
[13] 王维,段登艾,张勇辉,等.丙戊酸钠针剂与片剂快速改善双相情感障碍躁狂发作的疗效比较[J].国际精神病学杂志,2023,50(4):741-743,759.
[14] 冯仁健,陈前文,王华胜.丙戊酸钠联合喹硫平对双相障碍躁狂发作患者的效果[J].国际精神病学杂志,2023,50(6):1376-1379.
[15] 徐婷,尹灿灿,刘宝庆,等.心境稳定剂联合喹硫平或奥氮平治疗双相情感障碍躁狂发作疗效分析[J].解放军药学学报,2023,36(4):350-355.
[16] 刘燕林,李辉,周晓亮.不同剂量丙戊酸钠对双相情感障碍患者血清促甲状腺激素、泌乳素及多巴胺水平的影响[J].实用医学杂志,2024,40(1):97-101.
[17] 贺海玉,杨北辉,王寿森,等.双心境稳定剂联合安神汤在双相情感障碍躁狂发作中的应用[J].中国医师杂志,2024,26(4):611-613.
[18] 毛希祥,陈强,柏彩云,等.丙戊酸钠静脉滴注治疗双相障碍混合发作急性期的临床观察[J].临床精神医学杂志,2020,30(4):227-229.
[19] 谭亚倩,王占璋,卢浩扬,等.丙戊酸钠临床药物不良反应分析及合理用药[J].中国临床药理学杂志,2020,36(16):2501-2503.